Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282536
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-21
Brief Title:
Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC A Single Arm Exploratory Trial
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-21
First Submit QC Date:
February 21 2024
Study First Post Date:
2024-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-28
Last Update Post Date Type:
ACTUAL